Republicans urge Speaker Ryan to repeal device tax; AdvaMed partnering with Chinese city on device R&D;

@FierceMedDev: The top women in medical devices 2015. Feature | Follow @FierceMedDev

@VarunSaxena2: ICYMI yesterday: St. Jude earns FDA approval for recharge-free spinal cord stimulation system. Article | Follow @VarunSaxena2

@EmilyWFierce: Dx Digest: Invitae builds out cancer and epilepsy testing menus; Illumina gets in on autism research. More | Follow @EmilyWFierce

> Led by Rep. Elise Stefanik (R-NY) 44 freshman members of Congress sent a letter to new House Speaker Paul Ryan (R-WI) urging him to put a repeal of the medical device tax in a larger law by the end of the year. More

> AdvaMed signed a strategic cooperation framework agreement with the city of Xining, China, designed to promote cooperation between international med tech players and the emerging medical R&D hub, located in northwestern China. More

> Biotronik touted the results of a study of combination treatment of peripheral artery disease using its Passeo-18 Lux drug-coated balloon and Pulsar-18 self-expanding stent at the VEITH symposium in New York City. More

> Creagh Medical announced the acquisition of SurModics, a maker of percutaneous transluminal angioplasty balloon catheters. More

Biotech News

@FierceBiotech: TEDMED 2015: A brief history of CRISPR and what's next. Article | Follow @FierceBiotech

@JohnCFierce: To me, the FDA review of drisa reads like a letter to DMD parents. You don't want this drug. Please don't be angry. | Follow @JohnCFierce

@DamianFierce: "Did you name me after the mayor of New York, dad?" "Yes, Kristaps, but he was just a basketball player then." | Follow @DamianFierce

> FDA takes a dim view of BioMarin's DMD drug, citing 'contradictory' data. Story

> Samsung and Biogen verge on EU approval with an Enbrel biosimilar. Report

> AstraZeneca, Sanofi swap 210,000 compounds in no-cash deal. Article

Pharma News

@FiercePharma: Price controls loom for generic drugs in India next year. FiercePharmaAsia article | Follow @FiercePharma

@EricPFierce: ICYMI from FiercePharmaManufacturing: Baxalta Singapore plant gets FDA OK to produce Advate. Report | Follow @EricPFierce

> Horizon drops hostile takeover attack on Depomed after legal ruling. Report

> Merck KGaA rolls out big plans for expansion in Africa. Story

> Dr. Reddy's strikes back at AstraZeneca in purple pill courtroom battle. Article